Radioactive drug trial offers new hope for Tough-to-Treat brain tumors
NCT ID NCT04082520
Summary
This study is testing a radioactive drug called Lutathera for patients with a type of brain tumor called meningioma that cannot be removed by surgery and has continued to grow after radiation treatment. The drug is given through an IV and is designed to find and kill tumor cells. The main goal is to see if Lutathera can safely stop or slow the tumor's growth for at least six months in these patients who have few other treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.